Association between pyrethroid exposure and cardiovascular disease: A national population-based cross-sectional study in the US

Objective: Pyrethroids-containing products are widely used as commercial and household insecticides. While animal studies and clinical case reports have shown acute cardiovascular outcomes of pyrethroids exposure, little has been known on the effect of chronic pyrethroid exposure on cardiovascular d...

Full description

Bibliographic Details
Main Authors: Qingping Xue, An Pan, Ying Wen, Yichao Huang, Da Chen, Chun-Xia Yang, Jason HY Wu, Jie Yang, Jay Pan, Xiong-Fei Pan
Format: Article
Language:English
Published: Elsevier 2021-08-01
Series:Environment International
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0160412021001707
id doaj-3b94a09007274207a6c00bb3f383d2bb
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Qingping Xue
An Pan
Ying Wen
Yichao Huang
Da Chen
Chun-Xia Yang
Jason HY Wu
Jie Yang
Jay Pan
Xiong-Fei Pan
spellingShingle Qingping Xue
An Pan
Ying Wen
Yichao Huang
Da Chen
Chun-Xia Yang
Jason HY Wu
Jie Yang
Jay Pan
Xiong-Fei Pan
Association between pyrethroid exposure and cardiovascular disease: A national population-based cross-sectional study in the US
Environment International
Pyrethroids
3-phenoxybenzoic acid
Cardiovascular disease
Coronary heart disease
Stroke
author_facet Qingping Xue
An Pan
Ying Wen
Yichao Huang
Da Chen
Chun-Xia Yang
Jason HY Wu
Jie Yang
Jay Pan
Xiong-Fei Pan
author_sort Qingping Xue
title Association between pyrethroid exposure and cardiovascular disease: A national population-based cross-sectional study in the US
title_short Association between pyrethroid exposure and cardiovascular disease: A national population-based cross-sectional study in the US
title_full Association between pyrethroid exposure and cardiovascular disease: A national population-based cross-sectional study in the US
title_fullStr Association between pyrethroid exposure and cardiovascular disease: A national population-based cross-sectional study in the US
title_full_unstemmed Association between pyrethroid exposure and cardiovascular disease: A national population-based cross-sectional study in the US
title_sort association between pyrethroid exposure and cardiovascular disease: a national population-based cross-sectional study in the us
publisher Elsevier
series Environment International
issn 0160-4120
publishDate 2021-08-01
description Objective: Pyrethroids-containing products are widely used as commercial and household insecticides. While animal studies and clinical case reports have shown acute cardiovascular outcomes of pyrethroids exposure, little has been known on the effect of chronic pyrethroid exposure on cardiovascular disease (CVD). We aimed to examine the associations between chronic pyrethroid exposure and CVD in the US adults. Methods: Cross-sectional data from the National Health and Nutrition Examination Survey 1999–2002 and 2007–2012 were analyzed. The exposure to pyrethroids was determined as the urinary level of 3-phenoxybenzoic acid (3-PBA), and CVD was ascertained based on self-reported physician diagnoses. Multivariable logistic regression models were fitted to evaluate associations of pyrethroid exposure with CVD, coronary heart disease (CHD), and stroke. Results: Included were 6,471 participants with a mean age of 44.77 years (standard error, 0.39) for final analyses. The weighted prevalence of CVD, CHD, and stroke was 6.85%, 4.57% and 2.27%, respectively. With adjustments for major confounders, participants in the highest tertile of urinary 3-PBA had higher odds of CVD (odds ratio, 1.58; 95% confidence interval: 1.12, 2.23) and CHD (OR, 1.75; 95% CI: 1.17, 2.61) compared to those in the lowest tertile. There were linear associations for CVD (P for trend = 0.04) and CHD (P for trend = 0.02). However, no significant association was noted for stroke (1.29; 0.78, 2.16) in the main analyses. Conclusions: 3-PBA was adversely associated with CVD and CHD in the US adults. Our findings highlight potential cardiovascular risk of chronic exposure to pyrethroids, and should be validated in large prospective studies in different populations in future.
topic Pyrethroids
3-phenoxybenzoic acid
Cardiovascular disease
Coronary heart disease
Stroke
url http://www.sciencedirect.com/science/article/pii/S0160412021001707
work_keys_str_mv AT qingpingxue associationbetweenpyrethroidexposureandcardiovasculardiseaseanationalpopulationbasedcrosssectionalstudyintheus
AT anpan associationbetweenpyrethroidexposureandcardiovasculardiseaseanationalpopulationbasedcrosssectionalstudyintheus
AT yingwen associationbetweenpyrethroidexposureandcardiovasculardiseaseanationalpopulationbasedcrosssectionalstudyintheus
AT yichaohuang associationbetweenpyrethroidexposureandcardiovasculardiseaseanationalpopulationbasedcrosssectionalstudyintheus
AT dachen associationbetweenpyrethroidexposureandcardiovasculardiseaseanationalpopulationbasedcrosssectionalstudyintheus
AT chunxiayang associationbetweenpyrethroidexposureandcardiovasculardiseaseanationalpopulationbasedcrosssectionalstudyintheus
AT jasonhywu associationbetweenpyrethroidexposureandcardiovasculardiseaseanationalpopulationbasedcrosssectionalstudyintheus
AT jieyang associationbetweenpyrethroidexposureandcardiovasculardiseaseanationalpopulationbasedcrosssectionalstudyintheus
AT jaypan associationbetweenpyrethroidexposureandcardiovasculardiseaseanationalpopulationbasedcrosssectionalstudyintheus
AT xiongfeipan associationbetweenpyrethroidexposureandcardiovasculardiseaseanationalpopulationbasedcrosssectionalstudyintheus
_version_ 1721430856401158144
spelling doaj-3b94a09007274207a6c00bb3f383d2bb2021-05-22T04:35:22ZengElsevierEnvironment International0160-41202021-08-01153106545Association between pyrethroid exposure and cardiovascular disease: A national population-based cross-sectional study in the USQingping Xue0An Pan1Ying Wen2Yichao Huang3Da Chen4Chun-Xia Yang5Jason HY Wu6Jie Yang7Jay Pan8Xiong-Fei Pan9Department of Epidemiology and Biostatistics, School of Public Health, Chengdu Medical College, Chengdu, Sichuan, China; HEOA Group, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, ChinaDepartment of Epidemiology and Biostatistics, Ministry of Education & Ministry of Environmental Protection Key Laboratory of Environment and Health, and State Key Laboratory of Environmental Health (incubation), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, ChinaShenzhen Center for Disease Control and Prevention, Shenzhen, Guangdong, ChinaSchool of Environment and Guangdong Key Laboratory of Environmental Pollution and Health, Jinan University, Guangzhou, Guangdong, ChinaSchool of Environment and Guangdong Key Laboratory of Environmental Pollution and Health, Jinan University, Guangzhou, Guangdong, ChinaDepartment of Epidemiology and Biostatistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, ChinaThe George Institute for Global Health, University of New South Wales, Sydney, New South Wales, AustraliaInternational Clinical Research Center & Department of Neurology, Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, Chengdu, ChinaHEOA Group, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China; Institue for Healthy Cities, West China School of Public Health, Sichuan University, Chengdu, Sichuan, China; Corresponding authors at: Department of Epidemiology and Biostatistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, 3-17 Renmin Nanlu, Chengdu, Sichuan Province 610041, China (J. Pan). Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Rd, Wuhan 430030, China (X.-F. Pan).Department of Epidemiology and Biostatistics, Ministry of Education & Ministry of Environmental Protection Key Laboratory of Environment and Health, and State Key Laboratory of Environmental Health (incubation), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia; Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA; Corresponding authors at: Department of Epidemiology and Biostatistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, 3-17 Renmin Nanlu, Chengdu, Sichuan Province 610041, China (J. Pan). Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Rd, Wuhan 430030, China (X.-F. Pan).Objective: Pyrethroids-containing products are widely used as commercial and household insecticides. While animal studies and clinical case reports have shown acute cardiovascular outcomes of pyrethroids exposure, little has been known on the effect of chronic pyrethroid exposure on cardiovascular disease (CVD). We aimed to examine the associations between chronic pyrethroid exposure and CVD in the US adults. Methods: Cross-sectional data from the National Health and Nutrition Examination Survey 1999–2002 and 2007–2012 were analyzed. The exposure to pyrethroids was determined as the urinary level of 3-phenoxybenzoic acid (3-PBA), and CVD was ascertained based on self-reported physician diagnoses. Multivariable logistic regression models were fitted to evaluate associations of pyrethroid exposure with CVD, coronary heart disease (CHD), and stroke. Results: Included were 6,471 participants with a mean age of 44.77 years (standard error, 0.39) for final analyses. The weighted prevalence of CVD, CHD, and stroke was 6.85%, 4.57% and 2.27%, respectively. With adjustments for major confounders, participants in the highest tertile of urinary 3-PBA had higher odds of CVD (odds ratio, 1.58; 95% confidence interval: 1.12, 2.23) and CHD (OR, 1.75; 95% CI: 1.17, 2.61) compared to those in the lowest tertile. There were linear associations for CVD (P for trend = 0.04) and CHD (P for trend = 0.02). However, no significant association was noted for stroke (1.29; 0.78, 2.16) in the main analyses. Conclusions: 3-PBA was adversely associated with CVD and CHD in the US adults. Our findings highlight potential cardiovascular risk of chronic exposure to pyrethroids, and should be validated in large prospective studies in different populations in future.http://www.sciencedirect.com/science/article/pii/S0160412021001707Pyrethroids3-phenoxybenzoic acidCardiovascular diseaseCoronary heart diseaseStroke